Oncotarget: The First Study on CABYR Isoforms in Colorectal Cancer Oncotarget

In the cover paper of this week's issue of Oncotarget, titled: "The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy," researchers evaluate CABYR isoforms a/b and c mRNA expression in colorectal cancer in hopes of determining whether or not these proteins may be promising vaccine targets.
Read the full study here: https://doi.org/10.18632/oncotarget.27897
Oncotarget Volume 12, Issue 5: https://www.oncotarget.com/archive/v12/i5/

About Oncotarget:

Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit www.oncotarget.com or follow us:

SoundCloud - @oncotarget
Facebook - www.facebook.com/Oncotarget/
Twitter - twitter.com/oncotarget
LinkedIn - www.linkedin.com/company/oncotarget
Instagram - www.instagram.com/oncotargetjrnl/
YouTube - www.youtube.com/OncotargetYouTube
Pinterest - www.pinterest.com/oncotarget/
Reddit - www.reddit.com/user/Oncotarget/

Oncotarget is published by Impact Journals, LLC please visit www.ImpactJournals.com or connect with @ImpactJrnls

Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957x105